Total Payments
$18,358
2024 Payments
$114.41
Companies
44
Transactions
369
Medicare Patients
1,967
Medicare Billing
$187,719
Payment Breakdown by Category
Other$10,650 (58.0%)
Food & Beverage$6,883 (37.5%)
Travel$624.34 (3.4%)
Education$200.67 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,650 | 10 | 58.0% |
| Food and Beverage | $6,883 | 354 | 37.5% |
| Travel and Lodging | $624.34 | 2 | 3.4% |
| Education | $200.67 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $9,994 | 38 | $0 (2021) |
| Allergan, Inc. | $2,075 | 69 | $0 (2021) |
| LivaNova USA, Inc. | $1,753 | 17 | $0 (2021) |
| ABBVIE INC. | $720.57 | 48 | $0 (2023) |
| Amgen Inc. | $592.76 | 31 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $404.79 | 19 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $318.54 | 24 | $0 (2021) |
| Biogen, Inc. | $194.64 | 9 | $0 (2021) |
| Lilly USA, LLC | $153.79 | 9 | $0 (2022) |
| Grifols USA, LLC | $145.95 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.41 | 6 | PFIZER INC. ($73.41) |
| 2023 | $164.18 | 7 | Merz North America, Inc. ($51.53) |
| 2022 | $650.82 | 43 | ABBVIE INC. ($148.51) |
| 2021 | $12,685 | 158 | Biohaven Pharmaceuticals, Inc. ($9,994) |
| 2020 | $1,098 | 43 | Allergan, Inc. ($761.27) |
| 2019 | $2,474 | 48 | LivaNova USA, Inc. ($1,599) |
| 2018 | $524.89 | 26 | LivaNova USA, Inc. ($136.67) |
| 2017 | $646.63 | 38 | Teva Pharmaceuticals USA, Inc. ($226.34) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PAIN | ||||||
| 10/31/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: PAIN | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: PAIN | ||||||
| 07/18/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: VASCULAR | ||||||
| 05/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PAIN | ||||||
| 12/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $51.53 | General |
| Category: Musculoskeletal | ||||||
| 09/07/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: PAIN | ||||||
| 06/28/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2023 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Structural Heart | ||||||
| 01/05/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2022 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Immunology | ||||||
| 11/09/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: PRIMARY CARE | ||||||
| 10/26/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neuroscience | ||||||
| 10/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2022 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Immunology and Neurology | ||||||
| 10/05/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Central Nervous System | ||||||
| 10/04/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 481 | 552 | $149,972 | $44,587 |
| 2022 | 13 | 454 | 540 | $132,590 | $40,282 |
| 2021 | 16 | 630 | 708 | $184,815 | $67,354 |
| 2020 | 13 | 402 | 477 | $101,291 | $35,496 |
Total Patients
1,967
Total Services
2,277
Medicare Billing
$187,719
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 82 | 148 | $44,676 | $13,102 | 29.3% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2023 | 183 | 184 | $36,538 | $12,673 | 34.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 118 | 120 | $45,401 | $11,751 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,600 | $2,310 | 30.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $4,546 | $1,239 | 27.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 31 | 31 | $4,030 | $1,201 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 19 | $3,047 | $1,173 | 38.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 13 | $4,134 | $1,139 | 27.5% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2022 | 125 | 127 | $27,159 | $9,379 | 34.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 108 | $32,464 | $8,239 | 25.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 41 | $16,259 | $5,913 | 36.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 52 | $19,173 | $5,089 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 28 | $6,092 | $2,189 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $6,296 | $1,778 | 28.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 22 | $4,856 | $1,636 | 33.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 28 | $4,611 | $1,570 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $4,411 | $1,469 | 33.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 43 | $4,960 | $1,275 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 13 | 13 | $4,134 | $1,063 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $2,175 | $682.31 | 31.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 14 | 34 | $0.34 | $0.34 | 100.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 90 | 91 | $40,917 | $14,107 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 84 | $17,892 | $7,522 | 42.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 90 | 91 | $18,616 | $7,221 | 38.8% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Facility | 2021 | 48 | 48 | $12,288 | $4,955 | 40.3% |
About Dr. Richard Jackson, MD
Dr. Richard Jackson, MD is a Neurology healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1932427218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Jackson, MD has received a total of $18,358 in payments from pharmaceutical and medical device companies, with $114.41 received in 2024. These payments were reported across 369 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,650).
As a Medicare-enrolled provider, Jackson has provided services to 1,967 Medicare beneficiaries, totaling 2,277 services with total Medicare billing of $187,719. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Glens Falls, NY
- Active Since 05/11/2010
- Last Updated 01/15/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1932427218
Products in Payments
- NURTEC ODT (Drug) $10,238
- UBRELVY (Drug) $1,791
- VNS Therapy (Device) $1,735
- BOTOX (Biological) $712.73
- Aimovig (Biological) $332.42
- APTIOM (Drug) $318.54
- Repatha (Biological) $238.56
- AJOVY (Biological) $162.33
- Gamunex-C (Biological) $145.95
- EMGALITY (Drug) $135.19
- TROKENDI XR (Drug) $132.43
- QULIPTA (Drug) $128.81
- BOTOX THERAPEUTIC (Biological) $126.42
- Claria MRI (Device) $120.62
- OCREVUS (Biological) $116.58
- ADUHELM (Biological) $109.64
- CATALYST (Device) $105.00
- Fycompa (Drug) $101.37
- Briviact (Drug) $88.72
- APOKYN (Drug) $88.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.